Non-alcoholic Fatty Liver Disease NAFLD Clinical Trials

8 recruitingLast updated: June 18, 2026

There are 8 actively recruiting non-alcoholic fatty liver disease nafld clinical trials across 5 countries. Studies span Phase 1, Not Applicable, Phase 2. Top locations include Angers, France, France, Bécon-les-Granits, France, Baugé-en-Anjou, France. Updated daily from ClinicalTrials.gov.


Non-alcoholic Fatty Liver Disease NAFLD Trials at a Glance

8 actively recruiting trials for non-alcoholic fatty liver disease nafld are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 1 with 3 trials, with the heaviest enrollment activity in Angers, Bécon-les-Granits, and Baugé-en-Anjou. Lead sponsors running non-alcoholic fatty liver disease nafld studies include Corcept Therapeutics, University Hospital, Angers, and 1Globe Health Institute.

Browse non-alcoholic fatty liver disease nafld trials by phase

Treatments under study

About Non-alcoholic Fatty Liver Disease NAFLD Clinical Trials

Looking for clinical trials for Non-alcoholic Fatty Liver Disease NAFLD? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Non-alcoholic Fatty Liver Disease NAFLD trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Non-alcoholic Fatty Liver Disease NAFLD clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients

Liver FibrosisNon-alcoholic Fatty Liver Disease NAFLDAlcoholic Liver Disease (ALD)
University Hospital, Angers1,788 enrolled13 locationsNCT05699018
Recruiting
Phase 1

Evaluating the Pharmacokinetics and Safety of Miricorilant

Nonalcoholic Steatohepatitis (NASH)Non-alcoholic Fatty Liver Disease NAFLDMetabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis+1 more
Corcept Therapeutics15 enrolled1 locationNCT07553663
Recruiting

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease

Liver NeoplasmLiver FibrosisHBV Infection+1 more
Nanfang Hospital, Southern Medical University240 enrolled1 locationNCT07265544
Recruiting
Phase 1

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Nonalcoholic Steatohepatitis (NASH)Metabolic dysfunction-associated steatohepatitis (MASH)Non-alcoholic Fatty Liver Disease NAFLD+1 more
Corcept Therapeutics8 enrolled1 locationNCT06947304
Recruiting
Phase 2

Milk Thistle Clinical Trial in Pediatric NAFLD

Non-alcoholic Fatty Liver Disease NAFLD
University Hospitals Cleveland Medical Center20 enrolled1 locationNCT06477146
Recruiting
Not Applicable

Exploratory Study of MRI Biomarkers of NASH

Non-alcoholic Fatty Liver Disease NAFLD
University Hospital, Angers60 enrolled1 locationNCT06626074
Recruiting

Longitudinal Observational Study Of Chinese With NAFLD/NASH

Non-alcoholic Fatty Liver Disease NAFLDNon-Alcoholic Steatohepatitis(NASH)
Humanity and Health Research Centre20,000 enrolled1 locationNCT03151473
Recruiting
Phase 1

A Phase 1b Study of QX1206 in T2DM Patients With NAFLD

Type 2 Diabetes Mellitus (T2DM)Non-alcoholic Fatty Liver Disease NAFLD
1Globe Health Institute52 enrolled1 locationNCT06694935